Antibacterial and Antibiofilm Activity of Closantel Against Staphylococcus epidermidis
MicrobiologyOpen · 2025-10 · 14 (5)
DOI: 10.1002/mbo3.70062 ↗Kurz gefasst
Fachartikel in der Zeitschrift MicrobiologyOpen, online erschienen am 09.09.2025. Verfasst von Wu Pingyun und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, The Third Xiangya Hospital of Central South University, Changsha, China. Hauptthemen laut MEDLINE: Staphylococcus epidermidis, Biofilms, Anti-Bacterial Agents, Salicylanilides. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This study was supported by the Natural Science Foundation of Hunan Province (grant number 2024JJ5514)..
Abstract (Originalsprache)
Staphylococcus epidermidis is recognized as the major cause of implanted indwelling medical device‐related infections. The ability of S. epidermidis to form biofilms largely increases its resistance to conventional antibiotics, which is the major cause of treatment failure. Therefore, there is a pressing need to discover novel antimicrobials against S. epidermidis biofilms. In this study, Closantel (Clos), an antiparasitic drug, was repurposed to be effective against S. epidermidis planktonic cells with the minimal inhibitory concentration values of 0.25–0.5 μg/mL. Clos exhibited potent biofilm inhibition at ≥ 0.5 μg/mL and achieved effective eradication at ≥ 1 μg/mL. Notably, Clos induced lower resistance in S. epidermidis compared to Rifampicin. Mechanism study indicated that Clos exerted the bactericidal activity mainly through inducing bacterial cell membrane depolarization and further disruption. And the antibiofilm activity of Clos could be partially due to the inhibition of initial adhesion and extracellular polysaccharides production. In addition, CCK‐8 assay showed that Clos at 16 μg/mL had limited cytotoxicity in A2780, HaCaT and 293 T cells. In conclusion, this study demonstrates that Clos, a molecule targeting bacterial cell membranes, exhibits strong antimicrobial and antibiofilm effects in vitro against S. epidermidis . Although, side effects were reported in mammals, developing Clos derivatives could be still an effective therapeutic strategy to treat S. epidermidis ‐related infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, The Third Xiangya Hospital of Central South University, Changsha, China.
- Department of Laboratory Medicine, Shenzhen Hospital of Traditional Chinese Medicine, Shenzhen, China.
Förderung
- This study was supported by the Natural Science Foundation of Hunan Province (grant number 2024JJ5514).
Zitieren
APA
Pingyun, W., Yuan, W., Ruolan, W., Xueting, W., Qi, Y., & Pengfei, S. (2025). Antibacterial and Antibiofilm Activity of Closantel Against Staphylococcus epidermidis. MicrobiologyOpen, 14(5). https://doi.org/10.1002/mbo3.70062
Vancouver
Pingyun W, Yuan W, Ruolan W, Xueting W, Qi Y, Pengfei S. Antibacterial and Antibiofilm Activity of Closantel Against Staphylococcus epidermidis. MicrobiologyOpen. 2025;14(5). doi:10.1002/mbo3.70062
BibTeX
@article{Pingyun2025,
author = {Pingyun, Wu and Yuan, Wu and Ruolan, Wu and Xueting, Wan and Qi, Yang and Pengfei, She},
title = {Antibacterial and Antibiofilm Activity of Closantel Against Staphylococcus epidermidis},
journal = {MicrobiologyOpen},
year = {2025},
volume = {14},
number = {5},
doi = {10.1002/mbo3.70062}
}
EUVIMED